PRESS RELEASE published on 11/17/2025 at 17:50, 9 months 29 days ago Correction of a release from 17.11.2025 17:40 CET/CEST - VALBIOTIS SA: Valbiotis announces a major strategic agreement in Asia Valbiotis announces strategic agreement with Chinese group Aika to commercialize ValbiotisPRO® products in multiple Asian markets starting in 2026, leveraging CBEC model for rapid market entry Valbiotis Commercialization Asia Strategic Agreement Aika
BRIEF published on 11/17/2025 at 17:45, 9 months 29 days ago Valbiotis joins forces with Aika for a strategic partnership in Asia E-commerce Valbiotis International Strategy Aika Asian Joint Venture
PRESS RELEASE published on 11/17/2025 at 17:40, 9 months 29 days ago VALBIOTIS SA: Valbiotis announces a major strategic agreement in Asia Valbiotis announces a major strategic agreement in Asia with Chinese group Aika for the commercialization of health products in key markets, starting with ValbiotisPRO® range as early as 2026 Joint Venture Valbiotis Asia Strategic Agreement Health Products
BRIEF published on 10/13/2025 at 17:50, 11 months 3 days ago VALBIOTIS SA: Information on shares and voting rights Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF published on 10/13/2025 at 17:50, 11 months 3 days ago VALBIOTIS SA: Monthly update on share capital Share Capital Voting Rights Euronext Growth Regulation Valbiotis
BRIEF published on 10/09/2025 at 17:50, 11 months 7 days ago Valbiotis Publishes Interim Financial Results, Confirms Growth Path Growth Strategy Financial Results Valbiotis Dietary Supplements Commercial Expansion
PRESS RELEASE published on 10/09/2025 at 17:45, 11 months 7 days ago VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap Valbiotis publishes its interim financial statements, confirms roadmap with successful commercialization, cash position of €13.2M, and growth drivers for 2026. Increased engagement with partners and all financial ambitions through 2030 affirmed Cash Position Valbiotis Commercialization Interim Financial Statements Growth Drivers
PRESS RELEASE published on 10/09/2025 at 17:45, 11 months 7 days ago VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap Valbiotis publishes interim financial results with robust commercialization timeline, solid cash position and growth drivers activated, while confirming financial ambitions through 2030. International engagements with partners intensify Financial Results Cash Position Valbiotis Growth Drivers Commercialization Timeline
BRIEF published on 09/01/2025 at 11:45, 1 year ago VALBIOTIS: Information on Share Capital in August 2025 Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF published on 09/01/2025 at 11:45, 1 year ago Evolution of the share capital of Valbiotis SA Share Capital Voting Rights Euronext Growth Threshold Crossing Valbiotis SA
Published on 09/16/2026 at 23:45, 7 hours ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 9 hours 15 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 13 hours 50 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 15 hours 45 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 16 hours 45 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 04:25, 2 hours 19 minutes ago Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 6 hours 59 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 8 hours 11 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 9 hours 29 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 10 hours 17 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 17:45, 13 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 23 hours 45 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 12 hours ago Report on the Combined General Meeting of the 10th of September 2026